Caricamento...
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Schizophrenia is a complex disorder that involves several neurotransmitters such as dopamine, glutamate, and GABA. More recently, the endocannabinoid system has also been associated with this disorder. Although initially described as present mostly in the periphery, cannabinoid type-2 (CB2) receptor...
Salvato in:
| Pubblicato in: | Front Psychiatry |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7673393/ https://ncbi.nlm.nih.gov/pubmed/33329132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2020.587154 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|